KRAS and carcinoma: The Vogelstein and Fearon MSS model identifies the loss of APC/β-catenin in the initial formation of adenoma polyps, mutations in KRAS in the developing adenoma, and TP53, FBXW7, TCF7L2, and PTEN together with the loss of chromosome 18q in carcinomas.